Understanding the impact of COVID-19 on clinical research in the consumer healthcare space.
COVID-19 has accelerated many changes in clinical research, particularly in the consumer healthcare space. While natural health products are increasingly attractive to consumers, the pandemic has caused significant disruptions to the clinical trial enterprise. Felix Alt, Head of Clinical Operations at Analyze and Realize, discusses both the challenges and the opportunities COVID-19 has brought to clinical research and consumer healthcare. Tune in to learn about:
